poh: an alternative review of 2012

In the interest of providing a balanced view, I am providing an alternative review of 2012, as seen through the eyes of another regular poster, P.


January

Despite POH’S lead project being a transdermal product, P. provides the forum with a long list of all of the advantages that he perceives pills to have over patch, including patient preference.

Theres... a percieved ease of use with pills , you just pop em' albeit more freqently & thats it .

Not everyone agreed. Results of various studies were posted on the forum throughout the year, which consistently demonstrated 85-90% patient preference for patch.

The well-informed P. then ominously alerted the forum and the company

... we may have a trogan horse



February

P. wanted exposure for POH in the likes of 'The Washington Post'...but lamented that it would never happen because quality broadsheet tends to let the journals be their source.

In December, POH actually managed to gain coverage in the aforementioned “quality broadsheet”, where it was named as a top global emerging technology to watch in 2013. Nevertheless, it all lacked credibility, according to P.

P. then asserted that the problem was that tpm/oxy hasn't gained traction in the wider scientific/pharmaceutical community

No one seemed to have told that to Dr Christopher Herndon, a well qualified, reputable and influential specialist and spokesperson in the field of pain management. In a video that had been made just the previous month, Dr Herndon stated that there was an oxycodone patch “on the way.”



March

The share price had risen, prompting P. to helpfully speculate

Interesting trading recently, anyone considered 'money laundering' ?



April

P. was suddenly sounding more positive on the forum. Clever mate b. knew how to interpret this

im definitely not buying any more shares if p. is suddenly liking POH's chances !



May

The share price, along with most others at this time, did indeed fall. P., who has often stated that there’s too much emotion on this forum, calmly and helpfully contributed

The govt' screwed the offshore funds last nite doubling their tax !!! A bit of work on the home front Esra & quick !



June

The share price had slipped further and P. had found a threat in yet another oral oxycodone product which was just in early stage development. P. suggested that this was a reason to bail.

Perhaps Collegium might not blow oxtpatch away but it looks like making a big hole so I'm goin' to cash !

Mate b. wasn’t so sure that P. would permanently depart.

P. would put $100k into POH just to be able to cause mischief on this forum

A week later, the share price had duly dropped 10% and P. had an explanation ready for G.C.

The problem... has been caused by yourself & others



July

P. has always been a welcome and informed source of information about the POH inner sanctum. In July, he broke the bad news to forum members

...spirits are far from high at Clayton & I can understand why

In an attempt to inspire further confidence he asked

Why did the likes of Nestle & CSL both committed tech' aquirers come, look, understand & leave?”



August

Ever alert and willing to share, P. had now found yet another oral oxycodone threat that was destined to make POH’s patch history.

Mark Hutchinson at Adelaide Uni' appears to have nailed opiod abuse & has already recieved FDA enquiries mmmmmm



September

With the share price at new lows, P. helpfully speculated

...a precursor to patch developement problems ???

If the patch did perchance make it, P.’s opinion was that no big pharma would be interested in a deal for a long, long time.

I cant see big pharma signing off until the patch has been prescribed at patient level for a sustantial period



October

In October, as the share price weakened again, the calm P. helpfully suggested

If Alan Gray bails this could get ugly !... theres something wrong

He didn’t, and there wasn’t. The share price made a solid recovery. As P. explained it away

some good spruiking may have entranced the uninitiated



November

Curiously, P. had turned mildly bullish. Perhaps he had bought back in.

The figures may be smaller than percieved J. but its a contributing earn for POH & a ripper for ENA

But the share price didn’t keep rising, leading to a string of ominous warnings.

My own research , the qualitative variety... suggests concern on stability re' oxy

When the share price was at .14, P. helpfully advised

I'd buy around 12 to 12.5c

He took to predicting the future for those that held

Then one day the money's gone & they dont know where it is !

And he helpfully provided a timeline

if POH doesn't give the goods by early Feb ur guna be poorer bud'



December

Despite having frequently reminded us about his past as a securities dealer, a rather indiscrete reference by P., which pertained to the company, suggested that P. had forgotten to remind himself.

Then P., now the expert in fortune telling, offered free advice to the Executive

the executive (would) go broke as fortune tellers ! Perhaps Esra , Harry & co could sharpen up on a business course at UQ or Melbourne

Finally, before signing off for the year, P. wished me good luck in 2013. He then offered his final assessment of why the company and the share price had had a rough year.Nothing to do with him - it was all MY fault.

The passionate prognostics of your ilk have only harmed this coy '



So, yes, good luck to you too in 2013, P. Sorry that the Year of the Dragon wasn’t much to your liking. I’m confident that the Year of the Snake will suit you so much better.